01 · Adult inflammatory bowel disease · Biomedicine · 2025
A novel personalized microbiome-based treatment for inflammatory bowel disease
NostraBiome internal validation study results
Population and design
Patients with inflammatory bowel disease; internal validation study.
What was studied
Personalized microbiome modulation based on microbiome and clinical data evaluated for symptom control and remission outcomes.
Results reported
Improvements in symptoms and measures of remission are described. Definitions and analysis should be read in the full publication.

